Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression

Abstract Olfactory dysfunction is among the earliest features of Alzheimer’s disease (AD). Although neuropathological abnormalities have been detected in the olfactory bulb (OB), little is known about its dynamic biology. Here, OB- proteome analysis showed a stage-dependent synaptic proteostasis imp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mercedes Lachén-Montes, Andrea González-Morales, María Victoria Zelaya, Estela Pérez-Valderrama, Karina Ausín, Isidro Ferrer, Joaquín Fernández-Irigoyen, Enrique Santamaría
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/29858517ff7646809eb90c4f31b52069
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:29858517ff7646809eb90c4f31b52069
record_format dspace
spelling oai:doaj.org-article:29858517ff7646809eb90c4f31b520692021-12-02T16:08:00ZOlfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression10.1038/s41598-017-09481-x2045-2322https://doaj.org/article/29858517ff7646809eb90c4f31b520692017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09481-xhttps://doaj.org/toc/2045-2322Abstract Olfactory dysfunction is among the earliest features of Alzheimer’s disease (AD). Although neuropathological abnormalities have been detected in the olfactory bulb (OB), little is known about its dynamic biology. Here, OB- proteome analysis showed a stage-dependent synaptic proteostasis impairment during AD evolution. In addition to progressive modulation of tau and amyloid precursor protein (APP) interactomes, network-driven proteomics revealed an early disruption of upstream and downstream p38 MAPK pathway and a subsequent impairment of Phosphoinositide-dependent protein kinase 1 (PDK1)/Protein kinase C (PKC) signaling axis in the OB from AD subjects. Moreover, a mitochondrial imbalance was evidenced by a depletion of Prohibitin-2 (Phb2) levels and a specific decrease in the phosphorylated isoforms of Phb1 in intermediate and advanced AD stages. Interestingly, olfactory Phb subunits were also deregulated across different types of dementia. Phb2 showed a specific up-regulation in mixed dementia, while Phb1 isoforms were down-regulated in frontotemporal lobar degeneration (FTLD). However, no differences were observed in the olfactory expression of Phb subunits in progressive supranuclear palsy (PSP). To sum up, our data reflect, in part, the missing links in the biochemical understanding of olfactory dysfunction in AD, unveiling Phb complex as a differential driver of neurodegeneration at olfactory level.Mercedes Lachén-MontesAndrea González-MoralesMaría Victoria ZelayaEstela Pérez-ValderramaKarina AusínIsidro FerrerJoaquín Fernández-IrigoyenEnrique SantamaríaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mercedes Lachén-Montes
Andrea González-Morales
María Victoria Zelaya
Estela Pérez-Valderrama
Karina Ausín
Isidro Ferrer
Joaquín Fernández-Irigoyen
Enrique Santamaría
Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
description Abstract Olfactory dysfunction is among the earliest features of Alzheimer’s disease (AD). Although neuropathological abnormalities have been detected in the olfactory bulb (OB), little is known about its dynamic biology. Here, OB- proteome analysis showed a stage-dependent synaptic proteostasis impairment during AD evolution. In addition to progressive modulation of tau and amyloid precursor protein (APP) interactomes, network-driven proteomics revealed an early disruption of upstream and downstream p38 MAPK pathway and a subsequent impairment of Phosphoinositide-dependent protein kinase 1 (PDK1)/Protein kinase C (PKC) signaling axis in the OB from AD subjects. Moreover, a mitochondrial imbalance was evidenced by a depletion of Prohibitin-2 (Phb2) levels and a specific decrease in the phosphorylated isoforms of Phb1 in intermediate and advanced AD stages. Interestingly, olfactory Phb subunits were also deregulated across different types of dementia. Phb2 showed a specific up-regulation in mixed dementia, while Phb1 isoforms were down-regulated in frontotemporal lobar degeneration (FTLD). However, no differences were observed in the olfactory expression of Phb subunits in progressive supranuclear palsy (PSP). To sum up, our data reflect, in part, the missing links in the biochemical understanding of olfactory dysfunction in AD, unveiling Phb complex as a differential driver of neurodegeneration at olfactory level.
format article
author Mercedes Lachén-Montes
Andrea González-Morales
María Victoria Zelaya
Estela Pérez-Valderrama
Karina Ausín
Isidro Ferrer
Joaquín Fernández-Irigoyen
Enrique Santamaría
author_facet Mercedes Lachén-Montes
Andrea González-Morales
María Victoria Zelaya
Estela Pérez-Valderrama
Karina Ausín
Isidro Ferrer
Joaquín Fernández-Irigoyen
Enrique Santamaría
author_sort Mercedes Lachén-Montes
title Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
title_short Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
title_full Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
title_fullStr Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
title_full_unstemmed Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
title_sort olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during alzheimer’s disease progression
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/29858517ff7646809eb90c4f31b52069
work_keys_str_mv AT mercedeslachenmontes olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
AT andreagonzalezmorales olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
AT mariavictoriazelaya olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
AT estelaperezvalderrama olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
AT karinaausin olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
AT isidroferrer olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
AT joaquinfernandezirigoyen olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
AT enriquesantamaria olfactorybulbneuroproteomicsrevealsachronologicalperturbationofsurvivalroutesandadisruptionofprohibitincomplexduringalzheimersdiseaseprogression
_version_ 1718384642872049664